SCHEMBL5775962

SCHEMBL5775962

CC[C@H](N)Cc1ncc(-c2cccs2)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.37
ALDH1A1 P00352 9/20 0.37
HPGD P15428 7/20 0.37
NPC1 O15118 6/20 0.37
RAB9A P51151 6/20 0.37
SMN1; SMN2 Q16637 5/20 0.37
MAPT P10636 5/20 0.37
HSD17B10 Q99714 5/20 0.37
TDP1 Q9NUW8 2/20 0.37
FAAH O00519 1/20 0.37
CES1 P23141 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
TSHR P16473 1/20 0.37
CASP3 P42574 1/20 0.37
SENP8 Q96LD8 1/20 0.37
SENP7 Q9BQF6 1/20 0.37
SENP6 Q9GZR1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5763248 0.75 HPGD (0.43) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL13484387 0.74 FAAH (0.43) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL8291559 0.74 FAAH (0.38) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL13484009 0.70 ALDH1A1 (0.46) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL12262584 0.69 CYP2C19 (0.48) ALDH1A1RAB9ASMN1; SMN2CYP2C19MEN1
SCHEMBL12262043 0.69 CYP2C19 (0.48) ALDH1A1RAB9ASMN1; SMN2CYP2C19MEN1
SCHEMBL1425381 0.69 CYP2C19 (0.48) ALDH1A1RAB9ASMN1; SMN2CYP2C19MEN1
Hydrochloric Acid SCHEMBL5807316 0.69 FAAH (0.48) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL26616404 0.69 FAAH (0.60) KDM4EALDH1A1HPGDNPC1RAB9A
SCHEMBL10626253 0.68 ALDH1A1 (0.69) KDM4EALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1682524-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS Aventis Pharmaceuticals, Inc. (US) 2006-07-26 EP disclosed
WO-2005040142-A9 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMA INC (US) 2005-06-09 WO disclosed
WO-2005040142-A1 NOVEL KETO-OXADIAZOLE DERIVATIVES AS CATHEPSIN INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2005-05-06 WO disclosed